Drug profile · INN
hexaminolevulinate hydrochloride
CYSVIEW KIT
hexaminolevulinate hydrochloride (CYSVIEW KIT) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravesical. Current US regulatory status: approved.
Drug details — hexaminolevulinate hydrochloride
- US status
- approved
- Class
- —
- Route
- INTRAVESICAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
hexaminolevulinate hydrochloride (CYSVIEW KIT) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravesical. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is hexaminolevulinate hydrochloride?
hexaminolevulinate hydrochloride (CYSVIEW KIT) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravesical. Current US regulatory status: approved.
What is the brand name for hexaminolevulinate hydrochloride?
CYSVIEW KIT is a marketed brand name for hexaminolevulinate hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hexaminolevulinate hydrochloride?
hexaminolevulinate hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.